This is true. People can talk about "smart" money all they like but if you listened to the conference call after that failed trial, the analyts were justs as gobsmacked and punch drunk as everyone else. No-one knows how these trials are going to pan out. Not the company, not the "smart" money, not anybody. As the saying goes "There's no such thing as a sure thing." And in biotech this applies 10 fold.
SPL Price at posting:
58.5¢ Sentiment: Hold Disclosure: Held
